Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

BACKGROUND: Whether factor V Leiden is associated with lower bleeding risk in patients with acute coronary syndromes using (dual) antiplatelet therapy has yet to be investigated. METHODS AND RESULTS: We pooled data from 3 randomized clinical trials, conducted in patients with acute coronary syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoodi, Bakhtawar K., Eriksson, Niclas, Ross, Stephanie, Claassens, Daniel M. F., Asselbergs, Folkert W., Meijer, Karina, Siegbahn, Agneta, James, Stefan, Pare, Guillaume, Wallentin, Lars, ten Berg, Jurriën M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649290/
https://www.ncbi.nlm.nih.gov/pubmed/34459239
http://dx.doi.org/10.1161/JAHA.120.021115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649290/
https://www.ncbi.nlm.nih.gov/pubmed/34459239
http://dx.doi.org/10.1161/JAHA.120.021115

Ejemplares similares